Nitric Oxide Synthase: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 122: | Line 122: | ||
**[[4kcp]], [[4kcq]], [[4kcr]], [[4kcs]] - r-eNOS OD heme domain +thiophene carboximidamide derivative<br /> | **[[4kcp]], [[4kcq]], [[4kcr]], [[4kcs]] - r-eNOS OD heme domain +thiophene carboximidamide derivative<br /> | ||
**[[3eah]] – h-eNOS OD - human<br /> | **[[3eah]] – h-eNOS OD - human<br /> | ||
**[[3nos]] – h-eNOS OD+arginine<br /> | **[[3nos]], [[4d1o]] – h-eNOS OD+arginine<br /> | ||
**[[1m9j]] – h-eNOS OD+chlorzoxazone<br /> | **[[1m9j]] – h-eNOS OD+chlorzoxazone<br /> | ||
**[[1m9k]], [[1m9r]], [[4d1p]] – h-eNOS OD+ inhibitor<br /> | **[[1m9k]], [[1m9r]], [[4d1p]] – h-eNOS OD+ inhibitor<br /> | ||